"Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care
Abstract Background In palliative care, it can be challenging to distinguish between reduced consciousness related to the illness and sedation due to a potentially sedating drug (intended, or unintended). These differentiations are important because unintended sedation requires consideration of alte...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | BMC Palliative Care |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12904-025-01781-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849225876257898496 |
|---|---|
| author | Sabine H. Krauss Constanze Rémi Claudia Bausewein Jeremias Bazata Alina Grebe Christoph Ostgathe Jan Schildmann Eva Schildmann the iSedPall study group |
| author_facet | Sabine H. Krauss Constanze Rémi Claudia Bausewein Jeremias Bazata Alina Grebe Christoph Ostgathe Jan Schildmann Eva Schildmann the iSedPall study group |
| author_sort | Sabine H. Krauss |
| collection | DOAJ |
| description | Abstract Background In palliative care, it can be challenging to distinguish between reduced consciousness related to the illness and sedation due to a potentially sedating drug (intended, or unintended). These differentiations are important because unintended sedation requires consideration of alternative treatment options, and intentional sedation demands compliance with guidelines. The aim of the study, which was part of the consortium project iSedPall, was to determine cut-off values for drugs’ doses/dosing intervals which are expected to result in defined depth of sedation/continuous effect. Methods Group Delphi conducted in Germany with prior online survey. Based on a review of the literature, statements regarding cut-off values for drugs´ doses/dosing intervals which are expected to result in a defined depth of sedation/continuous effect were developed for 11 drugs. Consensus was defined as ≥ 75% agreement. Statements with lower agreement entered the next round of discussion. Between the rounds (5 small groups, 3 – 4 participants each), the results were presented and discussed. If necessary, statements were adapted for the following round. Participating experts were physicians, pharmacists, and nurses experienced in palliative care, mostly with over 10 years of professional experience. Results 25/30 invited experts participated in the online survey, 17 in the Group Delphi. 12/33 statements were consented in the survey. The initial questionnaire for the Group Delphi comprised 22 statements on ten drugs. After three rounds, consensus was reached for all statements, determining cut-off doses/dosing intervals for lorazepam, midazolam, diazepam, levomepromazine, haloperidol, melperone, pipamperone, propofol, dexmedetomidine, and trazodone. Conclusions This study for the first time provides evidence- and expert consensus-based data to support clinical judgements regarding sedating effects of a range of potentially sedating drugs commonly used in palliative care. |
| format | Article |
| id | doaj-art-e8f7b1eff7e3448c98aa0d659faa7d78 |
| institution | Kabale University |
| issn | 1472-684X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Palliative Care |
| spelling | doaj-art-e8f7b1eff7e3448c98aa0d659faa7d782025-08-24T11:57:16ZengBMCBMC Palliative Care1472-684X2025-06-0124111210.1186/s12904-025-01781-8"Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative careSabine H. Krauss0Constanze Rémi1Claudia Bausewein2Jeremias Bazata3Alina Grebe4Christoph Ostgathe5Jan Schildmann6Eva Schildmann7the iSedPall study groupDepartment of Palliative Medicine, LMU University Hospital, LMU MunichDepartment of Palliative Medicine, LMU University Hospital, LMU MunichDepartment of Palliative Medicine, LMU University Hospital, LMU MunichDepartment of Palliative Medicine, LMU University Hospital, LMU MunichDepartment of Palliative Medicine, LMU University Hospital, LMU MunichDepartment of Palliative Medicine, CCC Erlangen – EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)Institute for History and Ethics of Medicine, Interdisciplinary Center for Health Sciences, Martin Luther University Halle-WittenbergDepartment of Palliative Medicine, LMU University Hospital, LMU MunichAbstract Background In palliative care, it can be challenging to distinguish between reduced consciousness related to the illness and sedation due to a potentially sedating drug (intended, or unintended). These differentiations are important because unintended sedation requires consideration of alternative treatment options, and intentional sedation demands compliance with guidelines. The aim of the study, which was part of the consortium project iSedPall, was to determine cut-off values for drugs’ doses/dosing intervals which are expected to result in defined depth of sedation/continuous effect. Methods Group Delphi conducted in Germany with prior online survey. Based on a review of the literature, statements regarding cut-off values for drugs´ doses/dosing intervals which are expected to result in a defined depth of sedation/continuous effect were developed for 11 drugs. Consensus was defined as ≥ 75% agreement. Statements with lower agreement entered the next round of discussion. Between the rounds (5 small groups, 3 – 4 participants each), the results were presented and discussed. If necessary, statements were adapted for the following round. Participating experts were physicians, pharmacists, and nurses experienced in palliative care, mostly with over 10 years of professional experience. Results 25/30 invited experts participated in the online survey, 17 in the Group Delphi. 12/33 statements were consented in the survey. The initial questionnaire for the Group Delphi comprised 22 statements on ten drugs. After three rounds, consensus was reached for all statements, determining cut-off doses/dosing intervals for lorazepam, midazolam, diazepam, levomepromazine, haloperidol, melperone, pipamperone, propofol, dexmedetomidine, and trazodone. Conclusions This study for the first time provides evidence- and expert consensus-based data to support clinical judgements regarding sedating effects of a range of potentially sedating drugs commonly used in palliative care.https://doi.org/10.1186/s12904-025-01781-8Palliative sedationDeep sedationLight sedationPalliative careSufferingAdministration and dosage |
| spellingShingle | Sabine H. Krauss Constanze Rémi Claudia Bausewein Jeremias Bazata Alina Grebe Christoph Ostgathe Jan Schildmann Eva Schildmann the iSedPall study group "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care BMC Palliative Care Palliative sedation Deep sedation Light sedation Palliative care Suffering Administration and dosage |
| title | "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care |
| title_full | "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care |
| title_fullStr | "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care |
| title_full_unstemmed | "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care |
| title_short | "Is this sedation?” – a Group Delphi process to define cut-off doses and dosing intervals for potentially sedating drugs in palliative care |
| title_sort | is this sedation a group delphi process to define cut off doses and dosing intervals for potentially sedating drugs in palliative care |
| topic | Palliative sedation Deep sedation Light sedation Palliative care Suffering Administration and dosage |
| url | https://doi.org/10.1186/s12904-025-01781-8 |
| work_keys_str_mv | AT sabinehkrauss isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT constanzeremi isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT claudiabausewein isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT jeremiasbazata isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT alinagrebe isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT christophostgathe isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT janschildmann isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT evaschildmann isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare AT theisedpallstudygroup isthissedationagroupdelphiprocesstodefinecutoffdosesanddosingintervalsforpotentiallysedatingdrugsinpalliativecare |